Protein disulphide isomerase inhibitors
Patents for licensing
Never miss an update from Maciej Lojewski
Create your free account to connect with Maciej Lojewski and thousands of other innovative organizations and professionals worldwide
Technology Offer
Protein disulphide isomerase inhibitors
- Maciej from Jagiellonian University
- From Poland
- Responsive
- Patents for licensing
Summary of the technology
Protein disulphide isomerase (PDI) family is a group of enzymes regulating endoplasmic reticulum protein. In addition to well-known role of PDI as molecular chaperones, their cell-surface disulfide exchange activity controls thrombosis, cancer cell adhesion, metastasis and vascular function. Thus, protein disulphide isomerase seems to be an interesting therapeutic target to be exploited to afford anti-thrombotic, anti-metastatic and vasoprotective action.
Applications
anti-thrombotic; anti-coagulant; anti-metastatic; vasoprotective
Desired business relationship
Technology selling
Patent licensing
Technology development
Intellectual property status
- Patent already applied for
- Patent application number :PCT/PL2020/050004
Attached documents
Related Keywords
About Jagiellonian University
Jagiellonian University, founded 1364, is the oldest university in Poland and one of the oldest worldwide. The research and teaching activities are conducted at 15 faculties, including the Medical College (Collegium Medicum). Over 3,700 researchers work at the university and the total number of students is about 50,000.
Send a request for information
to Maciej
About Technology Offers
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Help
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support
